Drug Safety

Outliers and Patients with Adverse Drug Reactions
pp. 623-624(2)
Author: Edwards, I. Ralph

Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use?
pp. 625-636(12)
Authors: Hoet, Peter; Legiest, Barbara; Geys, Jorina; Nemery, Benoit

Serenoa repens (Saw Palmetto): A Systematic Review of Adverse Events
pp. 637-647(11)
Authors: Agbabiaka, Taofikat B.; Pittler, Max H.; Wider, Barbara; Ernst, Edzard

Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs: An Analysis of Patient Reports to the University of California, San Diego (UCSD) Statin Effects Study
pp. 649-661(13)
Authors: Golomb, Beatrice A.; Kwon, Edwin K.; Koperski, Sabrina; Evans, Marcella A.

Application of the Bow-Tie Model in Medication Safety Risk Analysis: Consecutive Experience in Two Hospitals in the Netherlands
pp. 663-673(11)
Authors: Wierenga, Peter C.; Lie-A-Huen, Loraine; de Rooij, Sophia E.; Klazinga, Niek S.; Guchelaar, Henk-Jan; Smorenburg, Susanne M.

Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan
pp. 675-690(16)
Authors: Hsiao, Fei-Yuan; Huang, Weng-Foung; Wen, Yu-Wen; Chen, Pei-Fen; Kuo, Ken N.; Tsai, Yi-Wen

Remedies Containing Asteraceae Extracts: A Prospective Observational Study of Prescribing Patterns and Adverse Drug Reactions in German Primary Care
pp. 691-706(16)
Authors: Jeschke, Elke; Ostermann, Thomas; Lüke, Claudia; Tabali, Manuela; Kröz, Matthias; Bockelbrink, Angelina; Witt, Claudia M.; Willich, Stefan N.; Matthes, Harald

Comment on “Drug-Induced Thrombocytopenia: An Updated Systematic Review”
pp. 707-707(1)
Authors: De Keulenaer, Bart L.; Cheah, Chan Y.

The Authors' Reply
pp. 708-708(1)
Author: George, James N.